Empirical evidence of risk penalties for NTI Drugs
Elissa Philip Gentry
| Year of publication: |
2019
|
|---|---|
| Authors: | Gentry, Elissa Philip |
| Published in: |
Journal of risk and uncertainty : JRU. - Dordrecht [u.a.] : Springer Science + Business Media, ISSN 0895-5646, ZDB-ID 59837-9. - Vol. 58.2019, 2/3, p. 219-244
|
| Subject: | Narrow therapeutic index drugs | NTI drugs | Generic substitution | Drug pricing | Pharmacy benefit managers | PBMs | Hedonic price | Pharmaceuticals | Arzneimittel | Pharmaindustrie | Pharmaceutical industry | Arzneimittelmarkt | Pharmaceutical market | Generika | Generic drugs | Hedonischer Preisindex | Hedonic price index | Gesundheitskosten | Health care costs | Preis | Price | Drogenkonsum | Drug consumption | Pharmahandel | Pharmaceutical distributors | Drogenpolitik | Drug policy | Droge | Drug | Arzneimittelrecht | Pharmaceutical law | Pharmakologie | Pharmacology |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1007/s11166-019-09304-6 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10012372762